Advertisement

Boston Scientific Corp. (NYSE: BSX) has launched its Promus Element Everolimus-Eluting Coronary Stent System and Taxus Element Paclitaxel-Eluting Coronary Stent System in India, noting that India is one of the world’s fastest growing drug-eluding stent markets. 

According to the Natick-based medical devices company, both Element Systems incorporate the same platinum chromium alloy, innovative stent design and advanced catheter delivery system. They represent the company’s third-generation drug-eluting stent technology.

SOURCE

Advertisement
Advertisement